BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 27181045)

  • 1. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions.
    León C; Ruiz-Santana S; Saavedra P; Castro C; Loza A; Zakariya I; Úbeda A; Parra M; Macías D; Tomás JI; Rezusta A; Rodríguez A; Gómez F; Martín-Mazuelos E;
    Crit Care; 2016 May; 20(1):149. PubMed ID: 27181045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.
    Martín-Mazuelos E; Loza A; Castro C; Macías D; Zakariya I; Saavedra P; Ruiz-Santana S; Marín E; León C
    Intensive Care Med; 2015 Aug; 41(8):1424-32. PubMed ID: 26134359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions.
    León C; Ruiz-Santana S; Saavedra P; Castro C; Ubeda A; Loza A; Martín-Mazuelos E; Blanco A; Jerez V; Ballús J; Alvarez-Rocha L; Utande-Vázquez A; Fariñas O
    Intensive Care Med; 2012 Aug; 38(8):1315-25. PubMed ID: 22752333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida albicans Germ-Tube Antibody: Evaluation of a New Automatic Assay for Diagnosing Invasive Candidiasis in ICU Patients.
    Parra-Sánchez M; Zakariya-Yousef Breval I; Castro Méndez C; García-Rey S; Loza Vazquez A; Úbeda Iglesias A; Macías Guerrero D; Romero Mejías A; León Gil C; Martín-Mazuelos E;
    Mycopathologia; 2017 Aug; 182(7-8):645-652. PubMed ID: 28378240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment.
    Martínez-Jiménez MC; Muñoz P; Valerio M; Vena A; Guinea J; Bouza E
    J Antimicrob Chemother; 2015 Nov; 70(11):3107-15. PubMed ID: 26311840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.
    Alam FF; Mustafa AS; Khan ZU
    BMC Infect Dis; 2007 Sep; 7():103. PubMed ID: 17784947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of (1->3)-β-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia.
    Held J; Kohlberger I; Rappold E; Busse Grawitz A; Häcker G
    J Clin Microbiol; 2013 Apr; 51(4):1158-64. PubMed ID: 23363830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients.
    Pemán J; Zaragoza R; Quindós G; Alkorta M; Cuétara MS; Camarena JJ; Ramírez P; Giménez MJ; Martín-Mazuelos E; Linares-Sicilia MJ; Pontón J;
    BMC Infect Dis; 2011 Mar; 11():60. PubMed ID: 21388550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of (1→3)-β-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida species.
    Mokaddas E; Burhamah MH; Khan ZU; Ahmad S
    BMC Infect Dis; 2010 Oct; 10():292. PubMed ID: 20923575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Candida albicans germ tube antibodies (CAGTA) and its association with (1 → 3)-β-D-glucan (BDG) for diagnosis of invasive candidiasis (IC).
    Pini P; Colombari B; Marchi E; Castagnoli A; Venturelli C; Sarti M; Blasi E
    Diagn Microbiol Infect Dis; 2019 Jan; 93(1):39-43. PubMed ID: 30098849
    [No Abstract]   [Full Text] [Related]  

  • 11. Candida biomarkers in patients with candidaemia and bacteraemia.
    Martínez-Jiménez MC; Muñoz P; Valerio M; Alonso R; Martos C; Guinea J; Bouza E
    J Antimicrob Chemother; 2015 Aug; 70(8):2354-61. PubMed ID: 25900160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of candidaemia in patients with and without underlying haematological disease.
    Arendrup MC; Bergmann OJ; Larsson L; Nielsen HV; Jarløv JO; Christensson B
    Clin Microbiol Infect; 2010 Jul; 16(7):855-62. PubMed ID: 20002683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive care medicine research agenda on invasive fungal infection in critically ill patients.
    Bassetti M; Garnacho-Montero J; Calandra T; Kullberg B; Dimopoulos G; Azoulay E; Chakrabarti A; Kett D; Leon C; Ostrosky-Zeichner L; Sanguinetti M; Timsit JF; Richardson MD; Shorr A; Cornely OA
    Intensive Care Med; 2017 Sep; 43(9):1225-1238. PubMed ID: 28255613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for the diagnosis of invasive candidiasis in immunocompetent and immunocompromised patients.
    Díez A; Carrano G; Bregón-Villahoz M; Cuétara MS; García-Ruiz JC; Fernandez-de-Larrinoa I; Moragues MD
    Diagn Microbiol Infect Dis; 2021 Nov; 101(3):115509. PubMed ID: 34384954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Invasive Candidiasis: From Gold Standard Methods to Promising Leading-edge Technologies.
    Pitarch A; Nombela C; Gil C
    Curr Top Med Chem; 2018; 18(16):1375-1392. PubMed ID: 30360714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of (1,3)-β-D-glucan, mannan, antimannan IgG and IgM antibodies in diagnosis of invasive candidiasis.
    Li F; Yu X; Ye L; Zhou G; Wang L; Luo Y
    Med Mycol; 2019 Nov; 57(8):976-986. PubMed ID: 30820536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic surveillance by Candida albicans germ tube antibody in intensive care unit patients.
    Trovato L; Astuto M; Castiglione G; Scalia G; Oliveri S
    J Microbiol Immunol Infect; 2020 Oct; 53(5):778-784. PubMed ID: 30902614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of mannan antigen and anti-mannan antibody screening in patients with haematological malignancies at risk for fungal infection.
    Duettmann W; Koidl C; Krause R; Lackner G; Woelfler A; Hoenigl M
    Mycoses; 2016 Jun; 59(6):374-8. PubMed ID: 26916753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study.
    Muñoz P; Vena A; Machado M; Gioia F; Martínez-Jiménez MC; Gómez E; Origüen J; Orellana MÁ; López-Medrano F; Fernández-Ruiz M; Merino P; González-Romo F; Frías I; Pérez-Granda MJ; Aguado JM; Fortún J; Bouza E;
    J Antimicrob Chemother; 2018 Mar; 73(suppl_4):iv6-iv12. PubMed ID: 29608751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of ß-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients.
    Guitard J; Isnard F; Tabone MD; Antignac M; Brissot E; Senghor Y; Petit A; Leverger G; Hennequin C
    J Infect; 2018 May; 76(5):483-488. PubMed ID: 29432826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.